First Header Logo Second Header Logo

Tildrakizumab: interpreting the data.

Purvis CG, Emmerich VK, Feldman SR. Tildrakizumab: interpreting the data. Br J Dermatol. 2021 08; 185(2):242-243.

View in: PubMed